Caxton Associates (New York)’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-25,576	Closed	-$615K	–	574
2022 Q3	$615K	Buy	+25,576	New	+$615K	0.08%	184
2020 Q2	–	Sell	-20,326	Closed	-$223K	–	594
2020 Q1	$223K	Buy	+20,326	New	+$223K	0.04%	322